AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Setglim M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Biospark Pharmaceuticals And Laboratories Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Setglim M 1mg/500mg Tablet SR

Glimepiride/Metformin extended-release tablets (1mg/500mg) are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation can elevate blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods or juice) are essential preventative measures. Alcohol consumption elevates hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.

Primary Ingredients of Setglim M 1mg/500mg Tablet SR

No text provided to rephrase.

Uses of Setglim M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Setglim M 1mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Setglim M 1mg/500mg sustained-release tablet should be administered with food.

Common Side effects of Setglim M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Setglim M 1mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet whole; avoid chewing, crushing, or fracturing it. Administer Setglim M 1mg/500mg Tablet SR with a meal.

How Setglim M 1mg/500mg Tablet SR works:

Setglim M 1mg/500mg sustained-release tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Setglim M 1mg/500mg SR tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Setglim M 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Setglim M tablets (1mg/500mg) are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Exercise caution when administering Setglim M 1mg/500mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. The use of Setglim M 1mg/500mg SR tablets is contraindicated in patients exhibiting severe kidney disease. Close monitoring of kidney function is recommended throughout the treatment period.

LiverLiverCAUTION

Patients with liver impairment should use Setglim M 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is advised. For those with mild to moderate liver disease, a low initial dose is typically recommended; however, its use is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Setglim M 1mg/500mg Tablet SR :

Should you forget a Setglim M 1mg/500mg SR Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.

Facts to Know About Setglim M 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Setglim M 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Setglim M 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Setglim M 1mg/500mg Tablet SR and seek immediate medical attention.
Setglim M 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Setglim M 1mg/500mg SR tablets may cause common side effects such as low blood sugar, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Setglim M 1mg/500mg SR tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Setglim M 1mg/500mg SR tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Setglim M 1mg/500mg SR tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Setglim M 1mg/500mg Table...
93
MRP 108
13% off